cho_logo_symbol_border

Tag: SARS-CoV

Study: An interactive web-based dashboard to track COVID-19 in real time

In response to COVID-19 ongoing public health emergency, we developed an online interactive dashboard, hosted by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University, Baltimore, MD, USA, to visualise and track reported cases of coronavirus disease 2019 (COVID-19) in real time.

Read More

Study: Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Numerous variants of SARS-CoV-2-harboring mutations in spike have arisen globally mRNA vaccines elicit potent neutralizing activity against homologous pseudovirus

Read More

Study: SARS-CoV-2 immune evasion by variant B.1.427/B.1.429

SARS-CoV-2 entry is mediated by the spike (S) glycoprotein which contains the receptor-binding domain (RBD) and the N-terminal domain (NTD) as the two main targets of neutralizing antibodies (Abs). A novel variant of concern (VOC) named CAL.20C (B.1.427/B.1.429) was originally detected in California and is currently

Read More

Long COVID (Post-Acute Sequelae of SARS CoV-2 infection, PASC)

Long COVID, or what doctors refer to as post-acute sequelae of COVID-19 (PASC), is a condition marked by the continuation of COVID-19 symptoms—or the emergence of new ones—after recovery from acute (or the initial phase of illness of) COVID-19.

Read More

CDC to Issue Guidelines As Long-Haul COVID Numbers Rise

The CDC is finalizing new guidelines for doctors on long-haul COVID-19.

Read More

Study: COVID-19 Can Kill Months After Infection

Long-haul COVID-19 patients face many health threats -- including a higher chance of dying -- up to 6 months after they catch the virus, according to a massive study published in the journal Nature.

Read More

4 Reasons Why Fake News is So Compelling

There’s nothing new about fake news. For as long as there has been news, there has been misinformation, both deliberate and unintentional.

Read More

Study: SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

Increased understanding of whether individuals who have recovered from COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We aimed to investigate whether antibodies against SARS-CoV-2 were associated with a decreased risk of symptomatic and asymptomatic reinfection.

Read More

Study: Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people

The clinical impact of the new SARS-CoV-2 lineage B.1·1.7 on children and young people (aged 18 years or younger) regarding acute respiratory COVID-19 is yet to be fully defined. Media reports of increases in admissions to hospital and more serious illness in children and young people

Read More

LONG-HAULERS ARE FIGHTING FOR THEIR FUTURE

Many people with long COVID feel that science is failing them. Neglecting them could make the pandemic even worse.

Read More

 

Our Journey to $1B+ Valuation

 

Disrupting Healthcare Testing / Diagnostics Early Detection of Cancer,
Chronic Conditions, Disease, Unlocking Anti-Aging Genomics & Promoting Longevity.

 

FUNDING GOAL $5,000,000

Funding Goal $5,000,000

20%

Skip to content